A Moral Imperative to Pursue Gene Editing Research?

A moral imperative to pursue gene editing research? The bioethicist Erik Parens has recently asked whether parents can be trusted with gene-editing technology, in a thought-provoking essay published in Aeon magazine. To set the stage, he writes that: “In April 2015, in the pages of Science, a group of prominent scientists and ethicists announced the […]

Read More…

Homeopathy, Blacklisting, and the Misuse of Choice

It seems that homeopathy might at last be facing some serious opposition from within the NHS, with the prospect of its being blacklisted being considered. There’s any number of people who’ll be entirely on board with that. Homeopathy doesn’t work.  Of course, a lot of medicines turn out not to work, or not to work […]

Read More…

Should Doctors Strike?

  Should doctors strike? Is it ethical for doctors to go on strike, potentially putting their patients at risk of getting inadequate treatment? As the BBC reports, ministers and junior doctors are currently “locked in a dispute.” One possible outcome of this disagreement is a physicians’ strike, which raises a number of tricky ethical questions. […]

Read More…

Stop What You’re Doing: This is Important.

I’d not realised it, but the latest iteration of the erstwhile Medical Innovation Bill – colloquially known as the Saatchi Bill – is up for debate in the Commons on Friday.  This is it in its latest form: to all intents and purposes, though, it’s the same thing about which I’ve blogged before. In a […]

Read More…

1 in 4 Women: How the Latest Sexual Assault Statistics Were Turned into Click Bait by the New York Times

by Brian D. Earp / (@briandavidearp) * Note: this article was originally published at the Huffington Post. Introduction As someone who has worked on college campuses to educate men and women about sexual assault and consent, I have seen the barriers to raising awareness and changing attitudes. Chief among them, in my experience, is a sense of skepticism–especially […]

Read More…

Flibanserin and Regulatory Failure

Guest Post by Adriane Fugh-Berman On August 18th, 2015, the FDA approved flibanserin (brand name Addyi), a purported aphrodisiac that can drop blood pressure so precipitously that users sometimes pass out and require medical intervention to regain consciousness.  The labelling for flibanserin indicates that it is for: the treatment of premenopausal women with acquired, generalized hypoactive […]

Read More…

Psychology Is not in Crisis? Depends on What You Mean by “Crisis”

By Brian D. Earp @briandavidearp *Note that this article was originally published at the Huffington Post. Introduction In the New York Times yesterday, psychologist Lisa Feldman Barrett argues that “Psychology Is Not in Crisis.” She is responding to the results of a large-scale initiative called the Reproducibility Project, published in Science magazine, which appeared to […]

Read More…